Intermittent androgen deprivation with the gonadotropin-releasing hormone (GnRH) antagonist degarelix in men with biochemical relapse of prostate cancer

KEANE -_Poster1_Page_1

pdfDOWNLOAD FULL POSTER

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe